Nicola Pavese Selected Research

Nicola Pavese Research Topics

Disease

48	Parkinson Disease (Parkinson's Disease) 01/2022 - 07/2002
12	Parkinsonian Disorders (Parkinsonism) 01/2021 - 10/2002
9	Neuroinflammatory Diseases 01/2021 - 04/2011
9	Huntington Disease (Huntington's Disease) 12/2018 - 05/2003
6	Tremor (Tremors) 01/2021 - 12/2005
5	Dyskinesias (Dyskinesia) 04/2011 - 07/2002
4	Disease Progression 01/2022 - 07/2009
4	Cognitive Dysfunction 10/2021 - 07/2017
3	Disorders of Excessive Somnolence (Hypersomnia) 01/2020 - 10/2015
3	Inflammation (Inflammations) 12/2018 - 01/2012
3	Fatigue 10/2015 - 01/2010
2	REM Sleep Behavior Disorder 10/2021 - 12/2020
2	Hypokinesia (Bradykinesia) 01/2020 - 01/2012
2	Alzheimer Disease (Alzheimer's Disease) 07/2017 - 12/2008
2	Movement Disorders (Movement Disorder) 01/2017 - 07/2012
2	Essential Tremor (Essential Tremors) 01/2017 - 01/2014
2	Dystonia (Limb Dystonia) 01/2016 - 12/2005
1	Brain Diseases (Brain Disorder) 01/2022
1	Olfaction Disorders (Cacosmia) 10/2021
1	Kuru 03/2019
1	Cerebral Infarction 01/2019
1	Multiple Sclerosis 01/2019
1	Wallerian Degeneration 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2018
1	Encephalitis (Encephalitis, Rasmussen) 07/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2016
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2016
1	HIV Infections (HIV Infection) 01/2014
1	Hyperammonemia 08/2013
1	Atrophy 06/2013
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2010
1	Dementia (Dementias) 01/2010
1	Sleep Wake Disorders 01/2010
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 10/2009
1	Psychotic Disorders (Schizoaffective Disorder) 10/2009
1	Fibrosis (Cirrhosis) 10/2007

Drug/Important Bio-Agent (IBA)

19	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 10/2002
9	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 07/2004
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2009
6	PK 11195 (PK11195)IBA 01/2019 - 02/2006
4	neuromelaninIBA 01/2022 - 01/2018
4	Cholinergic Agents (Cholinergics)IBA 10/2021 - 01/2010
4	SynucleinsIBA 10/2020 - 03/2015
4	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2020 - 11/2010
4	RacloprideIBA 01/2017 - 06/2004
4	Dihydroxyphenylalanine (Dopa)IBA 09/2013 - 10/2002
4	Dopamine Agonists (Dopamine Agonist)IBA 10/2007 - 07/2004
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 04/2012
3	AcetylcholinesteraseIBA 12/2020 - 03/2015
3	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2014
3	IronIBA 03/2018 - 07/2009
3	Dopamine Receptors (Dopamine Receptor)IBA 12/2016 - 05/2003
3	Methamphetamine (Desoxyn)FDA LinkGeneric 12/2005 - 05/2003
2	Pharmaceutical PreparationsIBA 01/2022 - 10/2015
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 07/2017 - 12/2008
2	Serotonin (5 Hydroxytryptamine)IBA 04/2012 - 11/2010
2	fluorodopa F 18IBA 01/2012 - 11/2009
1	opicaponeIBA 01/2022
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	CytokinesIBA 11/2020
1	Pattern Recognition ReceptorsIBA 11/2020
1	PrionsIBA 10/2020
1	Prion ProteinsIBA 03/2019
1	RadiopharmaceuticalsIBA 01/2019
1	SuspensionsIBA 12/2018
1	Mutant Proteins (Protein, Mutant)IBA 12/2018
1	rotigotine FDA Link 06/2018
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2017
1	Dopamine D3 ReceptorsIBA 12/2016
1	naxagolideIBA 12/2016
1	Donepezil (Aricept)FDA LinkGeneric 03/2015
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2014
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 09/2013
1	AmmoniaIBA 08/2013
1	Inositol (Myoinositol)IBA 01/2012
1	CreatineIBA 01/2012
1	Ion Channels (Ion Channel)IBA 04/2011
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2011
1	Glutamic Acid (Glutamate)FDA Link 04/2011
1	Cyanamide (Calcium Carbimide)IBA 04/2011
1	benzylamineIBA 11/2010
1	Neuroprotective AgentsIBA 12/2009
1	LigandsIBA 11/2008
1	NeuropeptidesIBA 11/2008
1	Apomorphine FDA Link 10/2007
1	Pergolide (Permax)FDA Link 10/2007
1	Cabergoline FDA LinkGeneric 10/2007
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 06/2006
1	Dopamine Agents (Dopaminergic Agents)IBA 05/2006

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2006
10	Deep Brain Stimulation 01/2022 - 07/2012
5	Denervation 01/2022 - 01/2012
4	Transplantation 12/2018 - 07/2002
2	Cell Transplantation 12/2018 - 06/2013
1	Investigational Therapies (Experimental Therapy) 01/2018
1	Parasympathectomy 03/2015